U.S. markets closed

Maison Luxe Inc. (MASN)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.2000-0.0100 (-4.76%)
At close: 2:11PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.2100
Open0.2400
BidN/A x N/A
AskN/A x N/A
Day's Range0.2000 - 0.2400
52 Week Range0.1000 - 1.5000
Volume29,230
Avg. Volume43,973
Market Cap178,571
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-1.6310
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • MAISON LUXE INC
    Analyst Report: Pfizer Inc.Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion. Pfizer also spends a leading amount on research and development, close to $8 billion annually. While Pfizer historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor.
    Rating
    Fair Value
    Economic Moat
    6 days agoMorningstar
View more
  • GlobeNewswire

    Maison Luxe to Commit Additional Capital for Its Multi-Million Dollar Relationship with Signet International Group

    FORT LEE, NJ, Aug. 24, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Maison Luxe, Inc. (OTC: MASN) (“Maison Luxe” or the “Company”), an emerging leader in the global custom luxury goods marketplace, is pleased to announce that it will be committing additional corporate capital toward the continued expansion of its agreement with Signet International Group (“Signet”) (SignetInternationalGroup.com), a leading player in marketing and distributing luxury branded products. Anil Idnani, CEO and Founder

  • GlobeNewswire

    Maison Luxe Investment Holding Aether Diamonds Starts Shipping the World's Only Carbon-Negative Diamonds

    FORT LEE, NJ, Aug. 12, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Maison Luxe, Inc. (“Maison Luxe” or the “Company”), an emerging leader in the global custom luxury goods marketplace, is pleased to update shareholders on the Company’s investment holding, Impossible Diamond, Inc, d/b/a Aether Diamonds (“Aether”), the first and only carbon-negative diamond producer in the world. Aether creates beautiful gemstone-quality precious diamonds entirely from capturing damaging excess CO2 from the Earth'

  • GlobeNewswire

    Maison Luxe Announces New $250k Purchase Order from Signet Int’l

    FORT LEE, NJ, Aug. 03, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Maison Luxe, Inc. (“Maison Luxe” or the “Company”), an emerging leader in the global custom luxury goods marketplace, is pleased to announce a new purchase order agreement (the “Agreement”) with Signet International Group (“Signet”) (SignetInternationalGroup.com), a leading player in marketing and distributing luxury branded products, whereby Maison Luxe will partner with Signet in the distribution of another $250k in luxury tim